Type II cryoglobulinemia in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma and Sjögren's disease

被引:0
|
作者
Bian, Renjie [1 ]
Yan, Xiaojing [1 ]
Zhang, Chaoxu [1 ]
Tao, Yuan [1 ]
Wang, Xiaoxue [1 ]
机构
[1] First Hosp China Med Univ, Dept Hematol, 155 Nanjing North St, Shenyang 110000, Liaoning, Peoples R China
关键词
Cryoglobulinemia; cryoglobulin; chronic lymphocytic leukemia; small lymphocytic lymphoma; Sj & ouml; gren's disease; rituximab; ibrutinib; dexamethasone; MONOCLONAL CRYOGLOBULINEMIA; MIXED CRYOGLOBULINEMIA; SJOGRENS-SYNDROME; VASCULITIS; GLOMERULONEPHRITIS; RITUXIMAB; RISK; IGG;
D O I
10.1177/03000605241285228
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Type II cryoglobulinemia is a rare disorder characterized by abnormal immunoglobulins (Igs) precipitating in the blood at low temperatures and redissolving upon warming. Sjogren's disease (SjD) is an autoimmune disorder involving secretory gland malfunction that leads to persistent dryness of the mouth and eyes. Here, we report the case of a 61-year-old woman with a 7-year history of SjD who was diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). However, her complicated clinical features could not be sufficiently explained by this disease alone. Immunofixation electrophoresis revealed monoclonal IgM-kappa and polyclonal IgG-kappa. The presence of precipitated cryoglobulin and elevated rheumatoid factor levels confirmed a diagnosis of type II cryoglobulinemia for this patient. To the best of our knowledge, this case represents the first report of a patient with CLL/SLL, SjD, and type II cryoglobulinemia, which increased our understanding of immune system-related disorders. Because certain similar mechanisms are involved in the pathogenesis of these three diseases, a combination treatment of rituximab, ibrutinib, and dexamethasone resulted in a favorable prognosis for this patient.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
    Barrientos, Jacqueline C.
    FUTURE ONCOLOGY, 2016, 12 (18) : 2077 - 2094
  • [2] Small Lymphocytic Lymphoma and Chronic Lymphocytic Leukemia Are They the Same Disease?
    Santos, Fabio P. S.
    O'Brien, Susan
    CANCER JOURNAL, 2012, 18 (05) : 396 - 403
  • [3] Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma
    Cencini, Emanuele
    Calomino, Natale
    Sicuranza, Anna
    Gozzetti, Alessandro
    Fabbri, Alberto
    Bocchia, Monica
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (06) : 501 - 505
  • [4] Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia
    Puckrin, Robert
    Owen, Carolyn
    Peters, Anthea
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 636 - 640
  • [5] Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Robak, Tadeusz
    Kasprzak, Jaroslaw D.
    Jesionek-Kupnicka, Dorota
    Chudobinski, Cezary
    Robak, Pawel
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [6] Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies
    Rainone, Michael
    Siddiqi, Tanya
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (01) : 39 - 45
  • [7] Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease
    Tees, Michael T.
    Flinn, Ian W.
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (02) : 137 - 146
  • [8] Concurrent cutaneous localization of Langerhans cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with a history of chronic lymphocytic leukemia/small lymphocytic lymphoma
    Papoudou-Bai, Alexandra
    Vassou, Amalia
    Marinos, Leonidas
    Papathanasiou, Konstantina
    Kapsali, Eleni
    Kanavaros, Panagiotis
    JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (02) : 161 - 165
  • [9] Updates in the management of chronic lymphocytic leukemia/small lymphocytic leukemia
    Hanna, Kirollos S.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (01) : 146 - 155
  • [10] A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma
    Woyach, J. A.
    Lin, T. S.
    Lucas, M. S.
    Heerema, N.
    Moran, M. E.
    Cheney, C.
    Lucas, D. M.
    Wei, L.
    Caligiuri, M. A.
    Byrd, J. C.
    LEUKEMIA, 2009, 23 (05) : 912 - 918